OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/13/2026 15:46
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization197,278 mln
Float3,188 mln
Earnings Date05/06/2026
EPS
3.60
Solid
P / E
12.95
Fair value
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.56
Likely reliable
1-Year Forecast
54.50
Attractive
Relative Strength
81
/ 100
Strongly outperforming
Business Description
Founded in Denmark in 1923, Novo Nordisk is a global pharmaceutical company best known for its treatments targeting diabetes and obesity, as well as rare conditions affecting the blood and hormonal system. The company develops and sells a range of medicines and delivery devices, including smart insulin pens and dosing tools, distributed across markets in North America, Europe, Asia, Latin America, and beyond.
